Zoetis inc stock.
The average price point forecasted by analysts for Zoetis Inc (ZTS) is $222.04, which is $66.19 above the current market price. The public float for ZTS is 459.99M, and currently, short sellers hold a 0.65% ratio of that floaft. The average trading volume of ZTS on October 31, 2023 was 1.63M shares.
Zoetis Announces First Quarter 2023 Results. May 4, 2023. Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $552 Million, or $1.19 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for First Quarter 2023. Delivers 4% Operational Growth in Revenue and a 3% Operational Decline in Adjusted …Explore all Zoetis Animal Health products for companion animal and livestock, as well as our innovative diagnostic solutions. Learn more.Stock buybacks reduce the number of shares outstanding, so the remaining shareholders receive. ... Zoetis Inc. (ZTS) Shareholder Yield . 2.5%. Forward 5-Year Annual EPS Estimate +15.6%.Benefits. Revolution Plus is the most prescribed medicine for feline parasite protection1. Building on the legacy of Revolution® (selamectin), Revolution Plus is now the trusted choice. Revolution Plus is an all-in-one solution—one application a month defends against roundworms, hookworms, and heartworm disease plus has a unique dual action ...
Rimma Driscoll ZTS stock SEC Form 4 insiders trading. Rimma has made over 1 trades of the Zoetis Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Rimma exercised 670 units of ZTS stock worth $120,017 on 11 February 2023.. The largest trade Rimma's ever made was exercising 670 units of Zoetis Inc …Vanessa Broadhurst ZTS stock SEC Form 4 insiders trading. Vanessa has made over 3 trades of the Zoetis Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Vanessa exercised 1,592 units of ZTS stock worth $272,670 on 10 February 2023.. The largest trade Vanessa's ever made was exercising 2,557 units of …US98978V1035. Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.
The intrinsic value of one ZTS stock under the Base Case scenario is 114.51 USD. Compared to the current market price of 179.13 USD, Zoetis Inc is Overvalued by ...
Zoetis Announces First Quarter 2022 Results. Reports Revenue of $2.0 Billion, Growing 6%, and Net Income of $595 Million, or $1.26 per Diluted Share, Increasing 6% and 8%, Respectively, on a Reported Basis for First Quarter 2022. Delivers 9% Operational Growth in Revenue and 8% Operational Growth in Adjusted Net Income for First Quarter 2022.Zoetis Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time ZTS stock price.As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70+ years of innovating ways to predict, prevent, detect and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide — from livestock farmers to …Zoetis Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ZTS updated stock price target summary.Nov 28, 2023 · On Monday, Zoetis Inc [NYSE:ZTS] saw its stock fall -0.79% to $178.79. On the same session, the stock had its day’s lowest price of $178.47, but rose to a high of $180.79. Over the last five days, the stock has gained 2.28%. Zoetis Inc shares have risen nearly 22.00% since the year began.
morningstar.com - November 21 at 3:47 PM. Zoetis to Participate in the Piper Sandler 35th Annual Healthcare Conference. finance.yahoo.com - November 21 at 10:29 AM. Bessemer Group Inc. Has $82.35 Million Stock Holdings in Zoetis Inc. (NYSE:ZTS) marketbeat.com - November 21 at 9:24 AM. Zoetis Inc. (NYSE:ZTS) EVP Roxanne …
Zoetis Inc. published this content on 10 January 2022 and is solely responsible for the information contained therein. Distributed by Public, ... Stock Zoetis Inc. - Nyse . News Zoetis Inc. Zoetis : Receives European Commission Marketing Authorization for APOQUEL® chewable tablets (oclacitinib) for the ...
Get the latest Zoetis Inc (ZOE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Zoetis (ZTS.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zoetis | Nyse: ZTS | NyseZoetis Inc. Class A Common Stock (ZTS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.The estimated Net Worth of Paul Bisaro is at least $37.2 Million dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $12,782,997 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.Zoetis. Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [5] [4] [6] The company was a subsidiary of Pfizer, [7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.Posted by u/stockinvest-us - 1 vote and no commentsZoetis Declares Fourth Quarter 2023 Dividend. PARSIPPANY, N.J., October 12, 2023--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the fourth ...
Sep 30, 2022 · PARSIPPANY, N.J. & RUTHERFORD, New South Wales, Australia--(BUSINESS WIRE)-- Zoetis Inc. (NYSE: ZTS) today announced it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures and markets a wide range of veterinary medicines for treating livestock and companion animals. Rimma Driscoll ZTS stock SEC Form 4 insiders trading. Rimma has made over 1 trades of the Zoetis Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Rimma exercised 670 units of ZTS stock worth $120,017 on 11 February 2023.. The largest trade Rimma's ever made was exercising 670 units of Zoetis Inc …Aug 8, 2023 · Zoetis Inc. ZTS delivered second-quarter 2023 adjusted earnings (excluding one-time items) of $1.41 per share, which beat the Zacks Consensus Estimate of $1.32 per share.In the year-ago quarter ... In the previous week, Boston Scientific had 6 more articles in the media than Zoetis. MarketBeat recorded 12 mentions for Boston Scientific and 6 mentions for Zoetis. Boston Scientific's average media sentiment score of 1.32 beat Zoetis' score of 0.64 indicating that Zoetis is being referred to more favorably in the news media.Our Story. At Zoetis, our purpose is to nurture our world and humankind by advancing care for animals. It’s an ambitious and humbling pursuit, but with a diverse and talented team supporting our customers all around the world, we’ve experienced 70+ years of success in animal health. Play the video. Home → Our Company → History.Read Our Latest Research Report on Zoetis. Zoetis Stock Up 1.6 %. NYSE ZTS traded up $2.91 during midday trading on Monday, hitting $182.04. 584,069 shares of the company traded hands, compared to ...
The estimated Net Worth of Paul Bisaro is at least $37.6 Milión dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,215,457 and over the last 11 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.See Best Monthly Dividend Stocks Model Portfolio for our top monthly income ideas. Growth Goal. ZTS. Target. Market- ...
ZTS - Zoetis Inc. Basic Chart, ... Zoetis stock jump 5% after earnings beat and upbeat guidance MarketWatch. Thursday, January 19, 2023. 12:55 PM ET. Finance Chiefs Hope New Congress Will Revisit Tax Rule on R&D Expenses The Wall Street Journal Interactive Edition.Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), BP p.l.c. (BP) and Zoetis Inc. (ZTS).Analyst Report: Zoetis Inc Find the latest Zoetis Inc. (ZTS) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance. Nov 13, 2023. finance.yahoo.com . Zoetis Inc. (ZTS) Q3 2023 Earnings Conference Call Transcript04/05/2023. Zoetis Foundation Announces First Round of 2023 Grants to Advance Farmer and Veterinarian Education, Livelihoods and Well-being. 03/30/2023. Zoetis to Host Webcast and Conference Call on First Quarter 2023 Financial Results. 03/13/2023. Zoetis Named One of the World’s Most Ethical Companies by Ethisphere.1.50 (0.99%) Ex-dividend date. 31 Oct 2023. 1y target est. 222.82. All. Press releases. Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.Zoetis Announces First Quarter 2023 Results. May 4, 2023. Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $552 Million, or $1.19 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for First Quarter 2023. Delivers 4% Operational Growth in Revenue and a 3% Operational Decline in Adjusted …
ZOETIS INC is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying …
Nov 22, 2023 · Zoetis Inc. (NYSE:ZTS) posted its quarterly earnings data on Tuesday, August, 8th. The company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.31 by $0.10. The business earned $2.18 billion during the quarter, compared to the consensus estimate of $2.16 billion.
Welcome to Zoetis. Dedicated to supporting customers and their businesses in ever better ways. Building on 60 years of experience, we deliver quality medicines and vaccines, complemented by diagnostic products and genetic tests and supported by a …So, based on the above formula, the ROE for Zoetis is: 48% = US$2.2b ÷ US$4.6b (Based on the trailing twelve months to June 2023). The 'return' is the income the business earned over the last year.May 4, 2023 · Zoetis Announces First Quarter 2023 Results. May 4, 2023. Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $552 Million, or $1.19 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for First Quarter 2023. Delivers 4% Operational Growth in Revenue and a 3% Operational Decline in Adjusted Net Income for First ... Zoetis Inc share price live 175.80, this page displays NYSE ZTS stock exchange data. View the ZTS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Zoetis Inc real time stock price chart below.FDA nod for NexGard Plus. Animal health company Zoetis Inc. ( NYSE: ZTS) traded higher Friday as analysts commented on the FDA approval of German drugmaker Boehringer Ingelheim's parasiticide ...13 abr 2023 ... Zoetis Inc. (ZTS) develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States ...Get the latest Home Depot Inc (HD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Zoetis ( ZTS 0.35%) is a leader in the pharmaceutical market for pets and livestock. It used to be a part of Pfizer ( PFE 0.07%), but was spun off in 2012. What makes Zoetis's business attractive ...Apr 20, 2023 · At Zoetis, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.
The estimated Net Worth of Gregory Norden is at least $9.76 Millón dollars as of 17 June 2023. Mr. Norden owns over 14,851 units of Zoetis Inc stock worth over $8,039,417 and over the last 11 years he sold ZTS stock worth over $1,360,615. In addition, he makes $355,000 as Independent Director at Zoetis Inc.Headquartered in Parsippany, New Jersey, Zoetis Inc. (NYSE:ZTS) is an animal health medicines, vaccines, and diagnostic products manufacturer. On February 28, 2023, Zoetis Inc. (NYSE:ZTS) stock ...Dec 1, 2023 · Grading Zoetis Inc Stock. Before you choose to buy, sell or hold Zoetis Inc stock, you’ll want to analyze how it has been graded. Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, making sense of financial ratios, reading income statements and analyzing recent stock movement. Instagram:https://instagram. monaco coachjim cramer stock marketfintech companies new jerseyvinfast ticker Dec 1, 2023 · Complete Zoetis Inc. stock information by Barron's. View real-time ZTS stock price and news, along with industry-best analysis. Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing. investing in platinum vs goldzqq Zoetis Inc. published this content on 10 January 2022 and is solely responsible for the information contained therein. Distributed by Public, ... Stock Zoetis Inc. - Nyse . News Zoetis Inc. Zoetis : Receives European Commission Marketing Authorization for APOQUEL® chewable tablets (oclacitinib) for the ...Select year: 11/02/2023 8:30 AM ET. Zoetis Quarterly Corporate Performance - Third Quarter 2023. Webcast. Presentation. 09/12/2023 12:55 PM ET. Morgan Stanley 21st Annual Global Healthcare Conference. senior vision insurance Zoetis Company Info. Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and ...64.05%. Get the latest Zoetis Inc (ZTS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …